ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,792, issued on Feb. 17, was assigned to Incyte Corp. (Wilmington, Del.).

"Solid forms of an FGFR inhibitor and processes for preparing the same" was invented by William Frietze (Kennett Square, Pa.), Zhongjiang Jia (Kennett Square, Pa.), Ming Tao (Maple Glen, Pa.) and Jiacheng Zhou (Newark, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, solid forms and polymorphs thereof, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the t...